Search
Fresolimumab
go.drugbank.com/drugs/DB12396InvestigationalFresolimumab has been used in trials studying the treatment of Primary Brain Tumors, Metastatic Breast Cancer, Diffuse Systemic Sclerosis, Pleural Malignant Mesothelioma, and Primary Focal Segmental Glomerulosclerosis
Lumretuzumab
go.drugbank.com/drugs/DB12683InvestigationalLumretuzumab has been used in trials studying the treatment of Neoplasms, Breast Cancer, Squamous Non-Small Cell Lung Cancer, and Non-Squamous Non-Small Cell Lung Cancer.
V590
go.drugbank.com/drugs/DB16437ExperimentalThe V590 vaccine was developed on Merck’s recombinant vesicular stomatitis virus (rVSV) platform that was previously used to develop its Ebola Zaire virus vaccine, ERVEBO®[A226818, L30573, L30578].
NV1020
go.drugbank.com/drugs/DB04969InvestigationalNV1020, a genetically engineered herpes simplex virus, is a novel anticancer therapeutic.
Entolimod
go.drugbank.com/drugs/DB12304InvestigationalEntolimod has been used in trials studying the treatment of Mucositis, Tongue Cancer, Colorectal Cancer, Stage IVA Verrucous Carcinoma of the Larynx, and Stage IVB Verrucous Carcinoma of the Larynx, among
ST-101
go.drugbank.com/drugs/DB12621InvestigationalST101 has been used in trials studying the treatment of Essential Tremor and Alzheimer's Disease.[A260411]
NP2
go.drugbank.com/drugs/DB06308InvestigationalIt was under investigation in clinical trial NCT01291901 (NP2 Enkephalin For Treatment of Intractable Cancer Pain).
Gestaclone
go.drugbank.com/drugs/DB21090ExperimentalGestaclone has a monoisotopic molecular weight of 370.17 Da.
Betoxycaine
go.drugbank.com/drugs/DB19475ExperimentalBetoxycaine has a monoisotopic molecular weight of 352.24 Da.
Motrazepam
go.drugbank.com/drugs/DB19799ExperimentalMotrazepam has a monoisotopic molecular weight of 325.11 Da.